Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic anti-migraine agents

Heterocyclic anti-migraine agents

US Patent 7569578 · Granted Aug 4, 2009

Estimated economic value: $74,200,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 in2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Method of improving acid decarboxylase activity in vitro under alkaline pH2025
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Aminotriazolopyridines as kinase inhibitors2024
Aminotriazolopyridines as kinase inhibitors2024
AD35-vectored immunogenic composition for SARS-COV-2 infection2024
Triazolopyridinyl compounds as kinase inhibitors2024
Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified re2024
Indazole carboxamides as kinase inhibitors2024